Skip to main content
Close
Publication

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.

See all publications
Not available in
This is not available in . You can go to the translated versions in these languages: